Objectives  To describe characteristics of patients with and without positive surgical margins (PSM) and describe the impact of PSM on secondary cancer treatment after radical prostatectomy (RP) with short-term follow-up.
Conclusions
 These data indicate an important association between hospital status and PSMs, with radical prostatectomy cases treated in private hospitals less likely than those in public hospitals to have PSM. Cases treated in lower volume hospitals were more likely to have PSM and less likely to receive additional treatment following surgery in the initial 12 months. Robot-assisted prostatectomy is associated with fewer positive surgical margins compared with the open approach in this non-randomised observational study.
Surgical margin status and pathological T3 disease are both important and independent predictor of secondary cancer treatment for patients undergoing radical prostatectomy.
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BACKGROUND
It is projected that in 2020 more than 25,000 new cases of prostate cancer will be diagnosed in Australia, more than any other cancer [1] . Prostate cancer is estimated to account for 15% of the cancer burden and 3% of the overall health burden in Australian men, second only to lung cancer [2] . Prostate cancer is principally a disease of older men, with the mean age of diagnosis being 68.4 years [2] .
Over the past 15 years there has been a shift towards earlier diagnosis of prostate cancer and increasing use of surgery to treat the disease [3] . Radical prostatectomy (RP) provides 15-year prostate cancer-specific survival of up to 93% [4] . While there are a number of surgical approaches which can be used, including open, laparoscopic and robot-assisted techniques, all have the same goal: to resect the local tumour and cure the disease whilst minimising side effects to the patient. One measure of the success of surgery is whether the cancer is contained within the resected prostate or has extended beyond the surgical margin. A review of the literature has identified the overall prevalence of positive surgical margins (PSM) to be 24% for open retropubic radical prostatectomy (ORP), 20% for laparoscopic radical prostatectomy (LRP) and 16% for robot-assisted laparoscopic radical prostatectomy (RALRP) [5] . The most well known risk factor associated with PSM is higher T category [6] . Other risk factors identified in the literature to varying extents include the skill of, and technique used by, the pathologist examining the specimen, [7, 8] pre-operative PSA level [6] , surgical technique [9] , surgical volume and surgeon experience [10] . PSM in organ-confined disease is widely regarded as a measure of surgical quality.
There is evidence that PSM post RP are independently associated with increased risk of biochemical progression, even after accounting for various pathological features, including
Accepted Article disease stage [6, 11] . The most striking effect is found for cases with intermediate and high risk disease [12] . There is less clear evidence of a link between PSM and metastases or death [6] .
A Cochrane systematic review [13] and evidence-based guidelines from Canada [14] , America [15] , Europe [16] , and Australia [17] suggest consideration of radiation treatment for men after RP, if found to have post-operative risk factors such as a PSM, pT3 disease, or a detectable PSA level. A secondary analysis of one of the three randomised comparative trials suggesting the benefit for postoperative treatment with radiation for men with high-risk disease noted the particular risk posed by a PSM [18] . A study of factors associated with the use of adjuvant therapies reported that patients with PSM were three times more likely than those without surgical margins to have additional treatment [19] .
Little is known about PSM prevalence in Australia and whether PSM influence additional treatment. No multicentre studies have evaluated variation in PSM and its association with subsequent care. The purpose of this analysis was to describe characteristics of patients with and without PSM and describe the association of PSM with secondary cancer treatment post RP. [20] .
METHODS
Prostatectomy
Inclusion and exclusion criteria
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Data collection
Histopathological data are captured through hospital information systems and pathology reports. Histopathological data are collected at time of diagnosis and surgery, but not on biopsy specimens taken subsequent to diagnosis but prior to surgery (for active surveillance patients).
Trained data collectors capture clinical information from medical records including treatment
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and PSA level at diagnosis, prior to treatment and the level immediately preceding the 12month follow-up date. In some instances a diagnosis was made in a notifying hospital and the patient subsequently underwent a RP at another hospital. In this situation the surgery data were requested by the notifying hospital. Cases are telephoned 12 months post diagnosis to confirm accuracy of treatment and most recent PSA level and collect quality of life information.
Periodically, hospitals are asked to validate biopsies and RPs against International Classification of Disease (ICD-10) codes to confirm complete capture of cases.
Statistical analysis and Institutional Review Board approval
The NCCN risk criteria for disease progression was used to classify cases into low, intermediate and high risk disease (see Box 1) [15] . Where the clinical T category was not recorded, if the Gleason score was ≤ 6 and the PSA was <10ng/mL, the patient was deemed to be at low risk for disease progression. Frequencies were used to describe predictors of PSM with two-sided level of significance determined using Chi-squared test. PSM was assessed by patient age at surgery using the Kruskal-Wallis equality-of-populations rank test. Significant predictors of PSM at univariate level were investigated using unadjusted and adjusted Poisson regression, clustering by surgeon. The adjusted model was tested for significant interaction effects between model covariates.
Time from diagnosis to RP was compared according to hospital type (private/public) and location (metropolitan/regional hospitals) using Kruskal-Wallis equality-of-populations rank test. To determine predictors of further treatment, data was dichotomised into surgery only and surgery with additional treatment. Chi-squared test was used to determine significance at a univariate level and logistic regression with clustering by surgeon was used to determine significance at a multivariate level. Radiotherapy was deemed to be immediate if it commenced within six months following surgery and delayed if it was delivered more than 6
Accepted Article months post-surgery. Stata/IC 12.0 (StataCorp, TX, USA) was used for all analyses and a twosided p-value <0.05 was considered to be statistically significant.
Ethical approval was gained from participating hospitals, Monash University and the Cancer Council Victoria. Patients having their surgery at private hospitals were less likely to have PSM than those having surgery in public hospitals l (IRR=0.76, CI: 0.63-0.93, p=0.006). Using the robotassisted approach was associated with a significantly lower likelihood of PSM compared with open approach (IRR=0.69, CI: 0.55-0.87, p=0.002) ( Table 3 ).
RESULTS
Predictors of further treatment
Patients treated at private hospitals were more likely than those treated at public hospitals to receive earlier surgery (median time from diagnosis to surgery=50 days (interquartile range (IQR)=35-77) vs 90 days (IQR= 64-133), p<0.001). Patients at metropolitan hospitals were more likely than those at regional hospitals to receive earlier surgery (median time from Independent factors associated with additional treatment post-surgery are outlined in Table 4 . 
DISCUSSION
The purpose of this analysis was to describe the prevalence of PSM and the influence of PSM on subsequent additional treatment in the 12 month period post diagnosis, using data from a contemporary cohort of patients enrolled in a prostate cancer registry. We found that PSM were present in the resections from 27% of cases treated by radical prostatectomy and that cases treated at private hospitals, and with a robot-assisted technique were less likely to have show small proportions of men (11.5%) with adverse pathology going on to postoperative radiation treatment [22] .
PSM prevalence following prostatectomy in Victoria may have declined over recent years; in a review of all Victorian radical prostatectomies in the period 1995-2000, the overall PSM prevalence was 31%. [23] Our identified overall PSM prevalence of 27% is less than the 34% identified in a study of 1383 patients contributing to the CaPSURE database, yet is significantly higher for the subgroup of cases with a diagnosis PSA of 0-4 ng/mL (PSM =63/344 or 18.3% vs 34/450 or 7.6%, Fisher's Exact p<0.001) [24] . The PSM prevalence of 25% for laparoscopic and 20% for robot-assisted radical prostatectomy in our study is high compared with that from a single site study of 200 laparoscopic and 200 robot-assisted cases which reported prevalences of 12 and 13.5% respectively [25] . Our open radical prostatectomy PSM prevalence of 33% is marginally less than the 35% reported by Smith et al., yet the robotassisted radical prostatectomy PSM prevalence of 15% reported by the same study is lower than ours (20%) [9] .
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Of interest was the finding that robot-assisted surgery was associated with a 30% decreased Accepted Article consultant surgeon while many undertaken at public hospitals are performed by trainees under supervision. Surgeon experience has been shown to affect PSM when laparoscopic [27] , open [28] , and robot-assisted [29] approaches are used. It may also indicate a difference in patient profile and specimen review processes across public and private hospitals. Of interest was our finding that there was no association between PSM prevalence and whether patients were treated in regional or metropolitan hospitals.
Our finding that patients having surgery performed at a low surgical volume hospital (defined as less than 10 cases/year) were more likely to have PSM compared with those treated at higher volume hospitals , even after taking into account surgical approach and disease stage, is at odds with Lawrentschuk et al's study, which was confined to cases with pathological stage T2 disease. [30] Chun et al similarly found that PSM was not affected by surgical volume for men with low and intermediate risk disease, but that surgeons who operated on higher volumes of high risk men could expect to have a significantly lower PSM prevalence compared with that of surgeons who operated on lower volume [31] . A limitation of both our study and Lawrenschuk's is that neither could analyse PSMs based on surgical volume, without knowledge of individual surgeon case-load outside the reporting hospitals. Sammon et al did not examine PSM prevalence but found that high surgical volume centres showed more favourable outcomes for both ORP and RARP in regard to most intraoperative and postoperative complications compared with low surgical volume hospitals. [32] Given that PSM are a known independent predictor of biochemical recurrence and cancerspecific mortality, a common goal of surgeons should be to avoid PSM where possible. In this paper we provide some indication of factors associated with high PSM in an Australian prostatectomy sample. However, there are a number of limitations to this study which may limit its interpretation. Importantly, we did not determine how specimens were sectioned, nor did we assess the experience of the pathologist undertaking the review, both of which have Accepted Article been associated with PSM status [7, 33] . A study by van der Kwast found that review of specimens by an expert urologic pathologist after an initial review by a general pathologist resulted in only 69.4% agreement (kappa=0. 45) in regard to PSM status [33] . Ekici et al found that partial sectioning of specimens resulted in good agreement between pathologists regardless of their level of experience, but when an expert pathologist employed complete sectioning technique there was a significant difference in PSM status [7] . Evans et al found that when 12 expert urologic pathologists compared their results, there was good sensitivity and specificity in determining PSM status (83.3% and 97.5% respectively) [8] . These studies suggest that both the technique and the experience of pathologist will affect interpretation of PSM status. Having a centralised pathology review system would provide greater understanding of whether the PSM differences identified in this study are the result of variation in the quality of the surgery or pathology review across sites. _ENREF_8
The Prostate Cancer Registry does not collect the site and number of positive margins so we were unable to report on location of the PSM. There is evidence that the prostate apex is the most common site of PSM and that postolateral margins place the patient most at risk for disease recurrence. [34] However, Grossfeld et al found that the number of positive margins and location of PSM had no significant impact on PSA recurrence nor on non-adjuvant secondary treatment [24] . Stephenson et al found that neither the number of PSMs or the location demonstrated enhanced capacity to predict biochemical recurrence over a simple model containing only whether the patient had positive or negative margins [35] . In addition, the PCR does not collect details of the patient's body mass index, which has also been shown to be associated with PSM [34] ._ENREF_15 As discussed earlier, another known limitation of our study is that, while the registry collects details of surgeon volume in contributing sites, it does not assess surgeon volume at non-participating sites, so the impact of individual surgeon volume-quality relationship on PSM and subsequent treatment could not be assessed. Finally,
as this was an observational study and not a randomised controlled clinical trial, we cannot rule out other patient factors which were not collected but might account for differences in PSM prevalence and subsequent treatments.
Conclusions
Radical prostatectomy cases with PSM are significantly more likely to receive additional treatment compared with those having clear surgical margins. Being treated at a private hospital using a robot-assisted technique appears to be associated with a lower risk of PSM even after taking into account the patient's age and disease stage. This needs further investigation as it may simply reflect surgeon experience and case selection. Any effort to reduce the frequency of PSM will undoubtedly also result in better outcomes, both in terms of patient psychological wellbeing and financial burden to the health system. Accepted Article 
